Search

everythinglearnresearchcommunity

for

Search:↓

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Researchers found four genes that could help diagnose severe alopecia areata early.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Vitiligo causes white skin patches and is linked to autoimmune issues.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Some congenital hair disorders improve in childhood or with treatments like minoxidil and retinoids, while others like Netherton syndrome and trichothiodystrophy have a poor prognosis.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

People with autoimmune skin diseases often have hearing problems and should get their hearing checked early.

A man with total hair loss also developed a rare nail condition, likely due to autoimmune issues.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Maintaining anticoagulation is crucial for patients with antiphospholipid syndrome.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Early treatment of mixed connective tissue disease is crucial to prevent severe autoimmune conditions.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.